Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib
This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib
This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib
Submitted by
admin
on August 31, 2012 - 12:27pm
Source:
Motley Fool
News Tags:
tivantinib
Arqule
lung cancer
Tarceva
Roche
Astellas
Headline:
This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib
Do Not Allow Advertisers to Use My Personal information
